Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-029925

10% owner sold 550,229 shares at $63.61 ($34,999,957)

From the SEC's structured data for this filing

Trades in this filing

Tactic Pharma LLC · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-24 Sale : show line 1 in the form −550,229 $63.61 $34,999,957 272,026 D
Open-market sales · 550,229 sh · avg $63.61 · $34,999,957
Loading xslF345X05/rdgdoc.xml…